- Terns Pharmaceuticals Inc., a global biopharmaceutical company focused on discovering and developing molecularly ...
- Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced results from a phase III, ...
- On December 20th, a decree from the President of France was published in Le Journal Officiel* appointing Denis DELVAL ...
- Celularity, Inc., a newly formed biotechnology company, today announced its acceleration of cell and tissue ...
- At a ceremony and symposium today, Waters Corporation (NYSE:WAT) welcomed into its Centers of ...
- LFB S.A., announced that its Biologic License Application (BLA), requesting marketing approval of ...
-AGC Asahi Glass ("AGC"), a world-leading manufacturer of glass, chemicals and high-tech materials, announced on ...
- Celgene Corporation (NASDAQ:CELG) today announced interim results from the ABOUND clinical trial program evaluating ...
- Singapore-based A. Menarini Asia-Pacific Holdings Pte Ltd (“Menarini Asia-Pacificâ€) and MSD have embarked ...
- Samsung Bioepis Co., Ltd. today announced that the European Medicines Agency’s (EMA) Committee for Medicinal ...
- HSRx Biopharmaceutical, a leading developer of polyfunctional-powered combination drugs for infectious ...
- Mitsubishi Tanabe Pharma Corporation (TSE: 4508), and Singapore-based A. Menarini Asia-Pacific Holdings Pte Ltd ...
- Merck's Consumer Health business takes the lead in addressing health and well-being challenges of ...
- Merck, a leading science and technology company, today announced the launch of its new consumer brand ...
- Samsung Bioepis Co., Ltd. today announced the European Commission’s (EC) approval of Benepali® – a ...